• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ARTL

ARTL

Artelo Biosciences, Inc.

NASDAQHealthcareBiotechnologyUS

USD1.46

+0.01 (+0.69%)

Rating:C

Company Profile

CEO

Gregory D. Gorgas

IPO Date

2019-06-21

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$1.40

Prev. Close

$1.45

Day Low

$1.35

Day High

$1.47

52W Low

$1.19

52W High

$85.80

Market Cap

$0.00B

Volume

0.26M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

16.8%

Avg Negative

6.7%

Avg Neutral

76.3%

News Feed

Artelo Biosciences, Inc. (ARTL) Q3 2021 Results - Earnings Call Transcript

Seeking Alpha·8/18/2021·↓ negative

Artelo Biosciences to Present at the Q3 Virtual Investor Summit on August 18th

Newsfile Corp·8/11/2021·↑ positive

Artelo Biosciences Announces Publication of Study Results Comparing the Pharmacological Effects of Plant-Derived Versus Synthetic Cannabidiol in Human Cell Lines

GlobeNewsWire
·8/4/2021
·↑ positive

Ladenburg Thalmann to Host R&D Showcase Featuring Artelo Biosciences' CAReS Study on July 28, 2021

GlobeNewsWire·7/21/2021·↑ positive

Artelo Biosciences Reports Third Quarter Fiscal 2021 Financial Results and Provides Business Update

GlobeNewsWire·7/12/2021·↑ positive

Relief For Cancer Patients In Artelo Bioscience Pipeline

Seeking Alpha·7/12/2021·↑ positive

Artelo Biosciences to Present at the LD Micro Virtual Invitational XI on June 9th

GlobeNewsWire·6/2/2021·↑ positive

Artelo Biosciences Reports Second Quarter Fiscal 2021 Financial Results and Provides Business Update

GlobeNewsWire·4/13/2021·↑ positive

Artelo Biosciences Doses First Patient in CAReS Study with ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss

GlobeNewsWire·4/12/2021·↑ positive

Artelo Biosciences, Inc. (ARTL) CEO Gregory Gorgas Presents at Q1 Virtual Investor Summit Conference (Transcript)

Seeking Alpha·3/23/2021·↑ positive